Info

Symbol Lon Pharmaceuticals, Inc. (Symbollon) is engaged in the development and commercialization of iodine-based pharmaceutical agents and antimicrobials. Symbollon has developed iodine technology that has the potential to maximize the therapeutic index of iodine. The therapeutic index of a drug is the ratio of the largest safe dose to the smallest effective dose. The Company’s technology accomplishes this by controlling the ratio of molecular iodine to the other inactive species of iodine typically present in solution. The Company has concentrated its product development work on the proposed product application for a treatment for fibrocystic breast disease. The Company’s iodine-based technology can be used in a number of product application areas, which can be grouped into women’s healthcare and infection control.(Source: 10KSB)